Alopecia

Latest News

Several Barriers Linked to Hindered Access of JAKi Therapy in Patients, Particularly Non-White, With Alopecia Areata
Several Barriers Linked to Hindered Access of JAKi Therapy in Patients, Particularly Non-White, With Alopecia Areata

May 1st 2024

These challenges may exacerbate racial inequities in care access and quality, according to a new study.

Countdown to RAVE!
Countdown to RAVE!

April 5th 2024

COVID-19 Impacts on Hair Loss, Pemphigus, Urticaria, and Rare Diseases
COVID-19 Impacts on Hair Loss, Pemphigus, Urticaria, and Rare Diseases

March 22nd 2024

Poster Presentations Demonstrate Efficacy of Deuruxolitinib in Patients With Moderate to Severe Alopecia Areata
Poster Presentations Demonstrate Efficacy of Deuruxolitinib in Patients With Moderate to Severe Alopecia Areata

March 18th 2024

What’s New in Hair Loss Therapies and Exosomes?
What’s New in Hair Loss Therapies and Exosomes?

March 12th 2024

More News

Pointers With Portela: Hair Loss Q&A

Pointers With Portela: Hair Loss Q&A

Dustin Portela, DO
March 6th 2024

In this week’s Pointers With Portela, the 208SkinDoc answers common hair loss questions.

Nektar Announces Initiation of Phase 2b Study for Rezpegaldesleukin in Severe, Very Severe Alopecia

Nektar Announces Initiation of Phase 2b Study for Rezpegaldesleukin in Severe, Very Severe Alopecia

Emma Andrus, Associate Editor
March 5th 2024

The study will evaluate rezpegaldesleukin and its effect on Severity of Alopecia Tool scoring by the conclusion of a 36-week period.

Experts Review Key Factors in Alopecia Areata Severity and Morbidity Index, Treatment Decisions

Experts Review Key Factors in Alopecia Areata Severity and Morbidity Index, Treatment Decisions

Cameron Santoro
March 4th 2024

Factors including disease duration, treatment response, and mental health were listed as crucial factors in severity and treatment.

© 2024 MJH Life Sciences

All rights reserved.